Literature DB >> 23549395

Precursors in cancer epidemiology: aligning definition and function.

Sholom Wacholder1.   

Abstract

A precursor of a disease is a definable pathologic state that progresses directly to disease without a known intermediate step and whose presence substantially increases the likelihood of disease. Precancers, or precursors of cancer, can help provide detail about the dynamic pathogenesis process before clinical disease. Thereby, ascertainment of properly defined precancers can increase precision of estimates and power in epidemiologic and clinical studies. Besides providing targets for direct treatment and improving tools for risk assessment in screening programs, precancers can help establish temporal ordering of cause and effect; can identify relatively homogeneous subsets of cancer that have passed through a given precancer state; and provide a basis for choosing high-risk individuals for detailed longitudinal study. Although the most appropriate definition of the precancer will vary with its function in particular research or clinical applications, the proportion of cancers that progress from the precancer and risk of cancer progressing from the precancer can be important measures of the value of a precancer in translational efforts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23549395      PMCID: PMC3738010          DOI: 10.1158/1055-9965.EPI-13-0084

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  36 in total

1.  Controls who experienced hypothetical causal intermediates should not be excluded from case-control studies.

Authors:  C Poole
Journal:  Am J Epidemiol       Date:  1999-09-15       Impact factor: 4.897

2.  The impact of a prevention effort on the community.

Authors:  Sholom Wacholder
Journal:  Epidemiology       Date:  2005-01       Impact factor: 4.822

Review 3.  Surrogate end points in clinical trials: are we being misled?

Authors:  T R Fleming; D L DeMets
Journal:  Ann Intern Med       Date:  1996-10-01       Impact factor: 25.391

4.  Case-control studies of the efficacy of screening tests designed to prevent the incidence of cancer.

Authors:  N S Weiss
Journal:  Am J Epidemiol       Date:  1999-01-01       Impact factor: 4.897

5.  Invited commentary: old problem, new wrinkles.

Authors:  J D Potter
Journal:  Am J Epidemiol       Date:  1998-05-15       Impact factor: 4.897

6.  Cigarette smoking and the colorectal adenoma-carcinoma sequence: a hypothesis to explain the paradox.

Authors:  M B Terry; A I Neugut
Journal:  Am J Epidemiol       Date:  1998-05-15       Impact factor: 4.897

7.  Re: Interpreting precursor studies: what polyp trials tell us about large-bowel cancer.

Authors:  J S Jacobson; A I Neugut
Journal:  J Natl Cancer Inst       Date:  1994-11-02       Impact factor: 13.506

8.  The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.

Authors:  Ana Cecilia Rodriguez; Robert Burk; Rolando Herrero; Allan Hildesheim; Concepcion Bratti; Mark E Sherman; Diane Solomon; Diego Guillen; Mario Alfaro; Raphael Viscidi; Jorge Morales; Martha Hutchinson; Sholom Wacholder; Mark Schiffman
Journal:  Sex Transm Dis       Date:  2007-07       Impact factor: 2.830

9.  Precancer: a conceptual working definition -- results of a Consensus Conference.

Authors:  Jules J Berman; Jorge Albores-Saavedra; David Bostwick; Ronald Delellis; John Eble; Stanley R Hamilton; Ralph H Hruban; George L Mutter; David Page; Thomas Rohan; William Travis; Donald E Henson
Journal:  Cancer Detect Prev       Date:  2006-10-31
View more
  9 in total

Review 1.  Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:  David P Steensma
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Genomics of adult and pediatric solid tumors.

Authors:  Zahraa Rahal; Farah Abdulhai; Humam Kadara; Raya Saab
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

3.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.

Authors:  David P Steensma; Rafael Bejar; Siddhartha Jaiswal; R Coleman Lindsley; Mikkael A Sekeres; Robert P Hasserjian; Benjamin L Ebert
Journal:  Blood       Date:  2015-04-30       Impact factor: 22.113

Review 4.  Clinical consequences of clonal hematopoiesis of indeterminate potential.

Authors:  David P Steensma
Journal:  Blood Adv       Date:  2018-11-27

5.  The Influence of Screening for Precancerous Lesions on Family-Based Genetic Association Tests: An Example of Colorectal Polyps and Cancer.

Authors:  Stephanie L Schmit; Jane C Figueiredo; Victoria K Cortessis; Duncan C Thomas
Journal:  Am J Epidemiol       Date:  2015-08-24       Impact factor: 4.897

Review 6.  Precocious cervical ripening as a screening target to predict spontaneous preterm delivery among asymptomatic singleton pregnancies: a systematic review.

Authors:  Qing Li; Mathew Reeves; John Owen; Louis G Keith
Journal:  Am J Obstet Gynecol       Date:  2014-07-11       Impact factor: 8.661

7.  Body mass index, diabetes, and mortality in French women: explaining away a "paradox".

Authors:  Martin Lajous; Anne Bijon; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Beverley Balkau; Françoise Clavel-Chapelon; Miguel A Hernán
Journal:  Epidemiology       Date:  2014-01       Impact factor: 4.822

8.  Ovarian Cancer Previvors: How to manage these patients?

Authors:  Jesus Paula Carvalho; Edmund Chada Baracat; Filomena Marino Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2019-07-22       Impact factor: 2.365

Review 9.  The role of gene sculptor microRNAs in human precancerous lesions.

Authors:  Ran-Hong Wang; Lan-Ying He; Shui-Hong Zhou
Journal:  Onco Targets Ther       Date:  2018-09-10       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.